Stock-based
compensation 1,846 2,147 5,778 7,114
Depreciation 3,043 1,941 7,895 5,743
Interest income, net (137) (459) (516) (1,265)
Adjusted EBITDA $3,629 $2,068 $8,677 $5,132
NOTE 4: Supplemental information related to the company's adjusted
EBITDA for the three and nine months ended September 28, 2008 and September
30, 2007 is presented for informational purposes only and is not prepared
in accordance with generally accepted accounting principles. Adjusted
EBITDA is defined as earnings before taxes, depreciation, and amortization
of intangible assets and non-cash marketing expense, adjusted to exclude
the impact of stock-based compensation expense.
SUPPLEMENTAL INFORMATION: Reconciliation of Forecasted Q4 2008 and FY 2008 Net Income (Loss) Range to Forecasted Q4 2008 and FY 2008 Adjusted EBITDA Range
Range Calculated As: Three Months Ended Twelve Months Ended
December 28, 2008 December 28, 2008
(In thousands, unless
otherwise indicated) Range High Range Low Range High Range Low
Net income (loss) $1,900 $400 $(6,675) $(8,175)
Amortization of
intangible assets 210 210 870 870
Amortization of
non-cash marketing 0 0 3,435 3,435
Stock-based
compensation 1,650 1,650 7,425 7,425
Depreciation 3,150 3,150 11,045 11,045
Interest income, net (110) (110) (625) (625)
Adjusted EBITDA $6,800 $5,300 $15,475 $13,975
SUPPLEMENTAL INFORMATION: Reconciliation of Net Cash Provided b
'/>"/>
| SOURCE drugstore.com, inc. Copyright©2008 PR Newswire. All rights reserved |